Sarepta Therapeutics Inc (SRPT)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 3,073,460 | 2,579,330 | 2,557,860 | 2,604,100 | 2,485,200 |
| Total current liabilities | US$ in thousands | 731,684 | 653,659 | 619,604 | 452,733 | 416,026 |
| Current ratio | 4.20 | 3.95 | 4.13 | 5.75 | 5.97 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $3,073,460K ÷ $731,684K
= 4.20
The current ratio of Sarepta Therapeutics Inc has shown a declining trend over the past few years. The ratio was at a robust level of 5.97 as of December 31, 2020, indicating that the company had a healthy level of current assets to cover its short-term liabilities. However, this ratio decreased to 5.75 by the end of 2021, and further dropped to 4.13 by the end of 2022.
This downward trend continued as the current ratio decreased to 3.95 as of December 31, 2023, indicating potential liquidity challenges in meeting short-term obligations. However, there was a slight improvement in the ratio to 4.20 by the end of 2024.
Overall, the decreasing trend in the current ratio suggests that Sarepta Therapeutics Inc may be facing challenges in maintaining an optimal level of current assets relative to its current liabilities. It is important for the company to closely monitor its liquidity position to ensure it can meet its short-term obligations effectively.
Peer comparison
Dec 31, 2024